Medical cannabis patients showed improved brain white matter structure after 3-6 months of treatment, with CBD exposure linked to improvements

Medical cannabis patients showed increased white matter coherence on MRI after 3 and 6 months of treatment, contrasting with impairments typically seen in recreational users, with improvements correlated to CBD exposure.

Dahlgren, Mary Kathryn et al.·Cannabis and cannabinoid research·2022·Moderate EvidenceProspective Cohort
RTHC-03784Prospective CohortModerate Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Prospective Cohort
Evidence
Moderate Evidence
Sample
N=14

What This Study Found

FA values (indicating white matter integrity) significantly increased in corpus callosum regions after 3 and 6 months of MC treatment. MD values (indicating demyelination when elevated) significantly decreased after 6 months. No changes were seen in a control brain region or in a pilot treatment-as-usual group. Reduced MD correlated with higher CBD but not THC exposure.

Key Numbers

37 MC patients; FA increased bilaterally in callosal regions at 3 and 6 months. MD decreased after 6 months. CBD exposure correlated with MD reduction. No changes in 14 treatment-as-usual controls.

How They Did This

Longitudinal study of 37 MC patients assessed via diffusion tensor imaging (DTI-MRI) before starting MC and at 3 and 6 months. Bilateral regions of interest including corpus callosum and internal capsule analyzed. A pilot treatment-as-usual comparison group (n=14) also assessed.

Why This Research Matters

This is the first study showing improved (not worsened) white matter coherence with cannabis use, suggesting medical cannabis patients, who tend to use CBD-containing products and start at older ages, may experience fundamentally different neural effects than recreational users.

The Bigger Picture

The contrast with recreational cannabis research, which typically shows white matter impairment, suggests the context of use matters enormously: product choice (CBD content), age of onset, and motivation for use may all influence neural outcomes.

What This Study Doesn't Tell Us

Small sample with attrition (37 to 22 over 6 months). Open-label, non-randomized. Patients chose their own products. Pilot control group was very small (n=14). Cannot separate MC effects from natural recovery from symptoms MC was treating.

Questions This Raises

  • ?Is CBD driving the white matter improvements?
  • ?Would recreational users who switch to CBD-rich products show similar improvements?
  • ?Are the white matter changes clinically meaningful?

Trust & Context

Key Stat:
White matter improved (not worsened) with medical cannabis use; CBD linked to gains
Evidence Grade:
Longitudinal MRI study with pilot control group, but small sample and open-label design.
Study Age:
Published in 2022.
Original Title:
Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment.
Published In:
Cannabis and cannabinoid research, 7(6), 827-839 (2022)
Database ID:
RTHC-03784

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Enrolls participants and follows them forward in time.

What do these levels mean? →

Frequently Asked Questions

Does medical cannabis damage the brain?

This study found the opposite: medical cannabis patients showed improved white matter structure on brain MRI over 6 months, contrasting with findings in recreational users. The improvements were linked to CBD exposure.

Why might medical cannabis be different from recreational use?

Medical cannabis patients typically start later in life, choose products with higher CBD content, and use for therapeutic purposes. These differences may explain why they showed brain improvements rather than the impairments seen in studies of recreational users.

Read More on RethinkTHC

Cite This Study

RTHC-03784·https://rethinkthc.com/research/RTHC-03784

APA

Dahlgren, Mary Kathryn; Gonenc, Atilla; Sagar, Kelly A; Smith, Rosemary T; Lambros, Ashley M; El-Abboud, Celine; Gruber, Staci A. (2022). Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment.. Cannabis and cannabinoid research, 7(6), 827-839. https://doi.org/10.1089/can.2022.0097

MLA

Dahlgren, Mary Kathryn, et al. "Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment.." Cannabis and cannabinoid research, 2022. https://doi.org/10.1089/can.2022.0097

RethinkTHC

RethinkTHC Research Database. "Increased White Matter Coherence Following Three and Six Mon..." RTHC-03784. Retrieved from https://rethinkthc.com/research/dahlgren-2022-increased-white-matter-coherence

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.